Casey Lippmeier, Vice President of Biotechnology Research for Sweegen, and Vice President of Research and Development for Conagen.
J. Casey Lippmeier, PhD. has more than 20 years of experience translating science into products in the biotechnology industry. Casey currently serves in two roles; Vice President of Biotechnology Research for Sweegen – a provider of delicious nature-based stevia sweeteners, and Vice President of Research and Development for Conagen Inc. – a fully integrated biomanufacturing company which uses synthetic biology to deliver high value ingredients for the food, flavor, nutritional, pharmaceutical, and renewable materials industries. Prior to joining Conagen and Sweegen, Casey was a Principal Scientist for DSM Nutritional Products, where he was an inventor of several diverse technologies including strains and processes for production of healthy fats, fermentation-based biodiesel, and a faster, better, and cheaper platform for production of many vaccines. Casey began his industrial career at Martek Biosciences where he helped to establish their molecular biotechnology group and while there developed the strains which still today produce the DHA and ARA used to fortify most infant formulas globally. Casey received his graduate training at Dartmouth College and the University of Hull, and undergraduate training at the University of Maine, Orono. He serves on the editorial board of several peer-reviewed journals and actively supports the DIYbio community as a board member of the Baltimore Underground Science Space.